Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China Pharmaceutical Investing
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Life Science Investing
Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes Pharmaceutical Investing
EnWave Announces Amendment to its Consulting Agreement with Adelaide Capital Markets Life Science Investing
BioVie Reviews Key Accomplishments from 2017 and Updates Phase 2a Clinical Trial Pharmaceutical Investing
Avalon GloboCare Appoints Dr. Bo Chen as Vice President of Mergers & Acquisitions Pharmaceutical Investing
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For Acne Treatment In Lotion Form Pharmaceutical Investing
